Our strategy

Home » About us » Our strategy

We develop and support life science to remove the barriers that prevent promising discoveries from becoming available to patients.

We identified areas with under-served healthcare needs – motor neuron disease, chronic respiratory infection, global health, rare disease, and childhood cancer – where our expertise in translational science can help the most. We call these ‘Translational Challenges’.

We collaborate with others already working in those areas to create better diagnostics and treatments by providing investment, expert scientific support and commercialisation advice.

Our Translational Challenges

Each Translational Challenge at LifeArc targets a specific area or disease with life science research that’s ripe for translation, and currently immature pipelines to get these discoveries to patients. We bring our science, advice and funding to these challenges, and also work closely with partners to tap into their expertise and capabilities.

Motor Neuron Disease

Our vision is a world where motor neuron disease is preventable and treatable.

Human brain with abstract visualization of neuron activity

Chronic Respiratory Infection 

Our vision is improved quality of life for those living with cystic fibrosis and bronchiectasis. 

Global Health

Our vision is a world with affordable and accessible solutions to better understand, treat, and prevent infectious diseases. 

Mycobacterium tuberculosis bacteria, bacterial disease, 3d render

Rare Disease

Our vision is an ecosystem working together to get discoveries and treatments to rare disease patients faster. 

Blue chromosome DNA and gradually glowing flicker light matter chemical when camera moving closeup. Medical and Heredity genetic health concept. Technology science. 3D illustration rendering

Childhood Cancer

Our vision is to drive life-changing innovations for children with cancer.

Focus on the under-served patient

As an independent, self-funded charity, we can focus on finding solutions to medical challenges that may be overlooked due to their complexity, high-risk nature, or commercial uncertainty.

We’re focused on delivering what patients tell us they most need, whether that’s a transformative new drug, diagnostic, device or digital solution.

There are many organisations and researchers already doing incredible work in these areas. Often, we seek to partner with them. Sometimes, we simply act as a bridge between experts.

A future proof LifeArc

We want to continue creating change for patients and building partnerships, long-term.

That means having a plan in place around our financial sustainability. Part of that is in our funding structure, including our early venture funding.

But we’re also concentrating on developing and retaining talent and building our reputation as a leader in translational science.

See how we’re funded

Bird-eye view of a group of young business people playing games in a cheerful atmosphere during a break at work. Business, people, company
Female Patient And Nurse Have Consultation In Hospital Room

Looking for more info about our approach and operations?

WordPress development by Andy White using PorterWP